{
    "clinical_study": {
        "@rank": "69", 
        "brief_summary": {
            "textblock": "RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill\n      them or deliver cancer-killing substances to them without harming normal cells. Drugs used\n      in chemotherapy use different way to stop cancer cells from dividing so they stop growing or\n      die. Combining monoclonal antibody therapy with chemotherapy may kill more cancer cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of rituximab plus fludarabine in treating\n      patients who have Waldenstrom's macroglobulinemia."
        }, 
        "brief_title": "Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia", 
        "condition": "Lymphoma", 
        "condition_browse": {
            "mesh_term": [
                "Lymphoma", 
                "Waldenstrom Macroglobulinemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the objective response and time to treatment failure in patients with\n           Waldenstrom's macroglobulinemia treated with rituximab and fludarabine.\n\n        -  Determine the toxicity of this regimen in these patients.\n\n        -  Determine if molecular remissions are achievable in patients attaining a clinical\n           complete response when treated with this regimen.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive rituximab IV over 3-6 hours once weekly on weeks 1-4, 17, 18, 30, and 31\n      and fludarabine IV over 10-30 minutes once daily for 5 days on weeks 5, 9, 13, 19, 23, and\n      27.\n\n      Patients are followed at least every 2 months for 2 years.\n\n      PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosis of Waldenstrom's macroglobulinemia\n\n          -  CD20 positive by bone marrow immunohistochemistry or flow cytometry\n\n          -  Presence of monoclonal paraprotein\n\n          -  IgM level at least 2 times upper limit of normal (ULN)\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Over 18\n\n        Performance status:\n\n          -  ECOG 0-2\n\n        Life expectancy:\n\n          -  At least 6 months\n\n        Hematopoietic:\n\n          -  Absolute neutrophil count greater than 1,000/mm^3\n\n          -  Platelet count greater than 25,000/mm^3\n\n        Hepatic:\n\n          -  Bilirubin less than 2.5 times ULN\n\n          -  SGOT less than 2.5 times ULN\n\n        Renal:\n\n          -  Creatinine less than 2.5 mg/dL\n\n        Other:\n\n          -  Not pregnant or nursing\n\n          -  Fertile patients must use effective contraception during and for 6 months after study\n\n          -  No serious comorbid disease\n\n          -  No uncontrolled bacterial, fungal, or viral infection\n\n          -  No other active malignancy\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  No prior rituximab\n\n          -  No prior nucleoside analogue therapy\n\n        Chemotherapy:\n\n          -  At least 30 days since prior chemotherapy\n\n        Endocrine therapy:\n\n          -  At least 30 days since prior steroid therapy\n\n          -  No concurrent corticosteroids\n\n        Radiotherapy:\n\n          -  At least 30 days since prior radiotherapy\n\n        Surgery:\n\n          -  Not specified\n\n        Other:\n\n          -  No more than 2 prior courses of therapy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "7", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 11, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00020800", 
            "org_study_id": "CDR0000068714", 
            "secondary_id": [
                "UCLA-0101063", 
                "NCI-G01-1960"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "rituximab", 
                "intervention_type": "Biological"
            }, 
            {
                "intervention_name": "fludarabine phosphate", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Fludarabine", 
                "Fludarabine monophosphate", 
                "Rituximab", 
                "Vidarabine"
            ]
        }, 
        "keyword": "Waldenstr\u00f6m macroglobulinemia", 
        "lastchanged_date": "January 7, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/UCLA-0101063"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "Arizona Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90048"
                    }, 
                    "name": "Cedars-Sinai Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90095-1781"
                    }, 
                    "name": "Jonsson Comprehensive Cancer Center, UCLA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Washington", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20307-5000"
                    }, 
                    "name": "Walter Reed Army Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush-Presbyterian-St. Luke's Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Iowa City", 
                        "country": "United States", 
                        "state": "Iowa", 
                        "zip": "52242-1009"
                    }, 
                    "name": "Holden Comprehensive Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21201"
                    }, 
                    "name": "Marlene and Stewart Greenebaum Cancer Center, University of Maryland"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Dana-Farber Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02111"
                    }, 
                    "name": "Tuft-New England Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Hyde Park", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11040"
                    }, 
                    "name": "Long Island Jewish Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "Memorial Sloan-Kettering Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45267-0502"
                    }, 
                    "name": "Barrett Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic Taussig Cancer Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edmonton", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T6G 1Z2"
                    }, 
                    "name": "Cross Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hamilton", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "L8N 3Z5"
                    }, 
                    "name": "Chedoke-McMaster Hospitals"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden", 
                        "zip": "SE-141 86"
                    }, 
                    "name": "Huddinge University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "EC1A 7BE"
                    }, 
                    "name": "Saint Bartholomew's Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada", 
                "Sweden", 
                "United Kingdom"
            ]
        }, 
        "official_title": "Phase II Study of Combination Rituxan (Rituximab, Mabthera) and Fludarabine Therapy in Lymphoplasmacytic Lymphoma (Waldenstrom's Macroglobulinemia)", 
        "overall_official": {
            "affiliation": "Jonsson Comprehensive Cancer Center", 
            "last_name": "Christos E. Emmanouilides, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "April 2003", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00020800"
        }, 
        "results_reference": {
            "PMID": "19015393", 
            "citation": "Treon SP, Branagan AR, Ioakimidis L, Soumerai JD, Patterson CJ, Turnbull B, Wasi P, Emmanouilides C, Frankel SR, Lister A, Morel P, Matous J, Gregory SA, Kimby E. Long-term outcomes to fludarabine and rituximab in Waldenstr\u00f6m macroglobulinemia. Blood. 2009 Apr 16;113(16):3673-8. Epub 2008 Nov 17."
        }, 
        "source": "Jonsson Comprehensive Cancer Center", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Jonsson Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }, 
    "geocoordinates": {
        "Arizona Cancer Center": "32.222 -110.926", 
        "Barrett Cancer Center": "39.103 -84.512", 
        "Cedars-Sinai Medical Center": "34.052 -118.244", 
        "Chedoke-McMaster Hospitals": "43.244 -79.889", 
        "Cleveland Clinic Taussig Cancer Center": "41.499 -81.695", 
        "Cross Cancer Institute": "53.544 -113.49", 
        "Dana-Farber Cancer Institute": "42.358 -71.06", 
        "Holden Comprehensive Cancer Center": "41.661 -91.53", 
        "Huddinge University Hospital": "59.329 18.065", 
        "Jonsson Comprehensive Cancer Center, UCLA": "34.052 -118.244", 
        "Long Island Jewish Medical Center": "40.735 -73.688", 
        "Marlene and Stewart Greenebaum Cancer Center, University of Maryland": "39.29 -76.612", 
        "Massachusetts General Hospital Cancer Center": "42.358 -71.06", 
        "Memorial Sloan-Kettering Cancer Center": "40.714 -74.006", 
        "Rush-Presbyterian-St. Luke's Medical Center": "41.878 -87.63", 
        "Saint Bartholomew's Hospital": "51.508 -0.128", 
        "Tuft-New England Medical Center": "42.358 -71.06", 
        "Walter Reed Army Medical Center": "38.895 -77.036"
    }
}